TotalMarketCap

Nanobiotix

NBTXNasdaq FranceHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.525 B

$30.01 +1.04%

Close of 6 Nov 2026

As of 6 Nov 2026, Nanobiotix (NBTX) has a market capitalization of $1.52B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

48,410,068

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #110Kailera TherapeuticsKLRA$1.58B
  2. #111Braveheart BioBRVE$1.57B
  3. #112NanobiotixNBTX$1.52B
  4. #113Nuvation BioNUVB$1.51B
  5. #114PrecigenPGEN$1.50B

What if Nanobiotix were worth as much as…

Open the what-if tool →

Gold $28.2T

$555,757.51

Per share 18,519× higher

Bitcoin $1.53T

$30,071.07

Per share 1,002× higher

Apple $5.02T

$98,720.52

Per share 3,290× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Nanobiotix are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.